Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 18,656 shares at $107.40 ($2.0M) on 2023-08-21, disclosed to the SEC on 2023-08-23.
Scheduled sale ($2.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $107.40 | 9,328 | $1.0M | 50.0% |
| 2 | $107.40 | 9,328 | $1.0M | 50.0% |
| Total | $107.40 avg | 18,656 | $2.0M | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |